SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 416 filers reported holding SAREPTA THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.97 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $61 | +7.0% | 500 | 0.0% | 0.01% | 0.0% |
| Q2 2023 | $57 | -17.4% | 500 | 0.0% | 0.01% | -16.7% |
| Q1 2023 | $69 | +6.2% | 500 | 0.0% | 0.01% | -14.3% |
| Q4 2022 | $65 | -99.3% | 500 | +400.0% | 0.01% | +600.0% |
| Q3 2021 | $9,000 | +12.5% | 100 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $8,000 | -88.6% | 100 | -80.0% | 0.00% | -93.3% |
| Q3 2020 | $70,000 | -12.5% | 500 | 0.0% | 0.02% | -31.8% |
| Q2 2020 | $80,000 | +63.3% | 500 | 0.0% | 0.02% | +46.7% |
| Q1 2020 | $49,000 | -24.6% | 500 | 0.0% | 0.02% | -16.7% |
| Q4 2019 | $65,000 | +71.1% | 500 | 0.0% | 0.02% | +38.5% |
| Q3 2019 | $38,000 | -50.0% | 500 | 0.0% | 0.01% | -48.0% |
| Q2 2019 | $76,000 | +26.7% | 500 | 0.0% | 0.02% | +19.0% |
| Q1 2019 | $60,000 | +9.1% | 500 | 0.0% | 0.02% | -8.7% |
| Q4 2018 | $55,000 | -51.3% | 500 | -28.6% | 0.02% | -45.2% |
| Q3 2018 | $113,000 | +22.8% | 700 | 0.0% | 0.04% | +35.5% |
| Q2 2018 | $92,000 | – | 700 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Evolutionary Tree Capital Management, LLC | 68,937 | $5,138,000 | 3.04% |
| Avoro Capital Advisors LLC | 2,150,000 | $160,240,000 | 2.77% |
| Casdin Capital, LLC | 550,000 | $40,992,000 | 1.22% |
| TOBAM | 371,107 | $27,659,000 | 1.18% |
| Ikarian Capital, LLC | 455,900 | $33,978,000 | 1.14% |
| Eventide Asset Management | 697,156 | $51,959,000 | 0.77% |
| FOX RUN MANAGEMENT, L.L.C. | 4,902 | $365,000 | 0.66% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 31,500 | $2,348,000 | 0.62% |
| Sivik Global Healthcare LLC | 20,000 | $1,491,000 | 0.54% |
| Rock Springs Capital Management LP | 328,750 | $24,502,000 | 0.54% |